CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | Dupont Jakob EVP, Head of R&D | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 272,500 | ||
| 2021-09-22 | Newell Joe Chief Operations Officer | Option exercise | +10,500 | $12.15 | $128K | 130,429 |
| 2021-09-22 | Newell Joe Chief Operations Officer | Sale | −10,500 | $17.00 | $179K | 119,929 |
| 2021-09-22 | Newell Joe Chief Operations Officer | Option exercise · Employee Stock Option (Right to Buy) | −8,375 | $17.00 | $142K | 34,875 |
| 2021-09-22 | Newell Joe Chief Operations Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,125 | $17.00 | $36K | 10,625 |
| 2021-09-15 | Newell Joe Chief Operations Officer | Sale | −3,116 | $15.61 | $49K | 119,929 |
| 2021-08-30 | Newell Joe Chief Operations Officer | Sale | −3,500 | $15.00 | $53K | 123,045 |
| 2021-08-17 | Touchon Pascal President and CEO | Sale | −8,223 | $12.53 | $103K | 336,891 |
| 2021-08-17 | Newell Joe Chief Operations Officer | Sale | −2,426 | $12.53 | $30K | 126,545 |
| 2021-08-17 | Murugan Amar SVP, GC & Secretary | Sale | −2,080 | $12.53 | $26K | 89,664 |
| 2021-08-17 | Koppikar Utpal Chief Financial Officer | Sale | −3,579 | $12.53 | $45K | 161,369 |
| 2021-08-17 | Dupont Jakob EVP, Head of R&D | Sale | −2,152 | $12.53 | $27K | 92,793 |
| 2021-08-09 | MALLIK AMEET Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2021-06-25 | Touchon Pascal President and CEO | Sale | −14,194 | $16.32 | $232K | 345,114 |
| 2021-06-14 | Yarema Kristin Chief Commercial Officer | Purchase | +3,500 | $14.48 | $51K | 97,049 |
| 2021-06-14 | Yarema Kristin Chief Commercial Officer | Purchase | +28,833 | $14.58 | $420K | 125,882 |
| 2021-06-11 | Yarema Kristin Chief Commercial Officer | Purchase | +2,021 | $14.50 | $29K | 93,549 |
| 2021-06-08 | Koppikar Utpal Chief Financial Officer | Sale | −5,820 | $14.06 | $82K | 164,948 |
| 2021-06-08 | SEIDENBERG BETH C Director | Grant or award | +11,000 | 38,189 | ||
| 2021-06-08 | SEIDENBERG BETH C Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +17,500 | 17,500 |
Page 13 of 17 · 334 trades